Curis Inc. (NASDAQ:CRIS) has been given a consensus rating of “Buy” by the seven analysts that are covering the firm. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $5.50.
CRIS has been the topic of several research reports. Zacks Investment Research upgraded shares of Curis from a “sell” rating to a “hold” rating in a research report on Monday, August 22nd. Robert W. Baird restated an “outperform” rating and set a $7.00 price objective on shares of Curis in a research report on Wednesday, September 7th. FBR & Co restated a “buy” rating on shares of Curis in a research report on Thursday, September 8th. Finally, RBC Capital Markets set a $7.00 price objective on shares of Curis and gave the company a “buy” rating in a research report on Wednesday, October 12th.
Curis (NASDAQ:CRIS) traded down 5.1691% during trading on Monday, reaching $3.1958. 189,859 shares of the company traded hands. The firm’s 50 day moving average price is $2.98 and its 200 day moving average price is $2.11. The firm’s market capitalization is $449.17 million. Curis has a 12-month low of $1.25 and a 12-month high of $3.72.
Curis (NASDAQ:CRIS) last posted its quarterly earnings data on Thursday, November 3rd. The company reported ($0.21) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.10) by $0.11. The company had revenue of $1.80 million for the quarter, compared to analysts’ expectations of $1.84 million. Curis had a negative net margin of 861.64% and a negative return on equity of 99.45%. The business’s quarterly revenue was down 14.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.04) EPS. Equities research analysts expect that Curis will post ($0.41) earnings per share for the current year.
In other news, major shareholder Discovery Technologie Aurigene purchased 10,208,333 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were acquired at an average price of $2.40 per share, with a total value of $24,499,999.20. Following the acquisition, the insider now directly owns 27,328,464 shares in the company, valued at $65,588,313.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 6.09% of the company’s stock.
A number of large investors have recently made changes to their positions in CRIS. Barclays PLC raised its stake in shares of Curis by 10,149.4% in the second quarter. Barclays PLC now owns 64,059 shares of the company’s stock worth $100,000 after buying an additional 63,434 shares during the period. Cornerstone Capital Management Holdings LLC. raised its stake in shares of Curis by 100.4% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 48,300 shares of the company’s stock worth $126,000 after buying an additional 24,200 shares during the period. Metropolitan Life Insurance Co. NY purchased a new stake in shares of Curis during the second quarter worth about $146,000. BlackRock Advisors LLC raised its stake in shares of Curis by 12.9% in the third quarter. BlackRock Advisors LLC now owns 57,569 shares of the company’s stock worth $150,000 after buying an additional 6,564 shares during the period. Finally, Prudential Financial Inc. purchased a new stake in shares of Curis during the third quarter worth about $158,000. 49.08% of the stock is currently owned by institutional investors and hedge funds.